Naoki Asano
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Naoki Asano has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Charlotte Boucheron
ICOA, UMR 6005 CNRS/Université d'Orléans rue de Chartres, B. P. 6759, 45067 Orléans, France, Fax: (+33) 238-417-281
1 shared publicationGuillaume Godin
ICOA, UMR 6005 CNRS/Université d'Orléans rue de Chartres, B. P. 6759, 45067 Orléans, France, Fax: (+33) 238-417-281
1 shared publicationKyoko Ikeda
Faculty of Pharmaceutical Sciences, Hokuriku University, Kanazawa 920-1181, Japan, Fax: (+81) 76-229-2781
1 shared publicationLiang Yu
Faculty of Pharmaceutical Sciences, Hokuriku University, Kanazawa 920-1181, Japan, Fax: (+81) 76-229-2781
1 shared publication- Olivier R. Martin
Université d'Orléans & CNRS, Institut de Chimie Organique et Analytique (ICOA), UMR 7311, Rue de Chartres, 45067 Orléans, France
1 shared publication - Philippe Compain
Institut de Chimie Organique et Analytique, Université d’Orléans, CNRS UMR 6005, BP 6759, 45067 Orléans, France
1 shared publication
Latest Publications
- 12 January 2009
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 66 (9) , 1479-1492
Sugar-mimicking glycosidase inhibitors: bioactivity and application
A large number of compounds mimicking the structures of monosaccharides or oligosaccharides have been discovered from natural sources. Such sugar mimics inhibit carbohydrate-degrading enzymes because of a structural resemblance to the sugar moiety of the natural substrate. Carbohydrate-degrading enzymes are involved in a wide range of important biological processes, such as intestinal digestion, posttranslational processing of the sugar chain of glycoproteins, their quality control mechanisms, lysosomal catabolism of glycoconjugates, and some viral infections. It has now been realized that inhibitors of the enzymes have enormous therapeutic potential in diabetes and lysosomal storage disorders. In this review, the general bioactivity, current applications, and the prospects for new therapeutic applications are described.
- 12 January 2009
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 66 (9) , 1479-1492
Sugar-mimicking glycosidase inhibitors: bioactivity and application
A large number of compounds mimicking the structures of monosaccharides or oligosaccharides have been discovered from natural sources. Such sugar mimics inhibit carbohydrate-degrading enzymes because of a structural resemblance to the sugar moiety of the natural substrate. Carbohydrate-degrading enzymes are involved in a wide range of important biological processes, such as intestinal digestion, posttranslational processing of the sugar chain of glycoproteins, their quality control mechanisms, lysosomal catabolism of glycoconjugates, and some viral infections. It has now been realized that inhibitors of the enzymes have enormous therapeutic potential in diabetes and lysosomal storage disorders. In this review, the general bioactivity, current applications, and the prospects for new therapeutic applications are described.
- 28 August 2006
- Published by Wiley in ChemBioChem
- Vol. 7 (9) , 1356-1359
Design and Synthesis of Highly Potent and Selective Pharmacological Chaperones for the Treatment of Gaucher's disease
- 28 August 2006
- Published by Wiley in ChemBioChem
- Vol. 7 (9) , 1356-1359
Design and Synthesis of Highly Potent and Selective Pharmacological Chaperones for the Treatment of Gaucher's disease